13D Filing: OrbiMed Advisors and Intellia Therapeutics Inc (NTLA)

(c)

Seller	Date of Transaction	Transaction	Number of Shares	Price Per Share*
OPI V	November 1, 2017	Sold	14,034	$29.15
OGH	November 1, 2017	Sold	4,266	$29.15
OPI V	November 1, 2017	Sold	1,103	$30.30
OGH	November 1, 2017	Sold	335	$30.30
OPI V	November 2, 2017	Acquired upon the exercise of stock options	6,039	$18
OGH	November 2, 2017	Acquired upon the exercise of stock options	1,804	$18
OPI V	November 2, 2017	Sold	6,039	$22.50
OGH	November 2, 2017	Sold	1,804	$22.50
OPI V	November 3, 2017	Sold	42,964	$22.00
OGH	November 3, 2017	Sold	13,057	$22.00
OPI V	November 6, 2017	Sold	16,670	$21.58
OGH	November 6, 2017	Sold	5,067	$21.58
OPI V	November 7, 2017	Sold	15,032	$21.14
OGH	November 7, 2017	Sold	4,568	$21.14
OPI V	November 8, 2017	Sold	5,675	$19.86
OGH	November 8, 2017	Sold	1,725	$19.86

__________________________

* The Price Per Share reported above is a weighted average price.  The shares of Common Stock were sold in multiple transactions at prices ranging from:  $29.00 to $29.99 (November 1, 2017); $30.00 to $30.99 (November 1, 2017); $21.80 to $22.24 (November 3, 2017); $21.29 to $22.05 (November 6, 2017); $20.75 to $21.55 (November 7, 2017) and $19.64 to $19.97 (November 8, 2017).  Upon request, the Reporting Persons undertake to provide the Issuer, any security holder of the Issuer, or the SEC full information regarding the shares of Common Stock purchased at each separate price within the ranges set forth above.

Except as disclosed above, the Reporting Persons have not effected any transactions in the shares during the past sixty (60) days.

(d)          Not applicable.

(e)          Not applicable.

Item 6.

Contracts, Arrangements, Understandings or Relationship with Respect to Securities of the Issuer

In addition to the relationships between the Reporting Persons described in Items 2, 3 and 5 above, GP V is the sole general partner of OPI V, pursuant to the terms of the limited partnership agreement of OPI V.  OGH GP is the sole general partner of OGH, pursuant to the terms of the limited partnership agreement of OGH. Advisors is the sole managing member of GP V and OGH GP, pursuant to the terms of the limited liability company agreement of GP V and OGH GP respectively.  Pursuant to these agreements and relationships, Advisors and GP V have discretionary investment management authority with respect to the assets of OPI V and Advisors and OGH GP have discretionary investment management authority with respect to the assets of OGH.  Such authority includes the power of GP V to vote and otherwise dispose of securities purchased by OPI V and OGH GP to vote and otherwise dispose of securities purchased by OGH.  The number of outstanding shares of Common Stock attributable to OPI V is 1,943,338 shares of Common Stock.  The number of outstanding shares of Common Stock attributable to OGH is 594,296 shares of Common Stock.  Advisors may be considered to have indirect beneficial ownership of 2,537,684 shares of Common Stock.  Isaly, pursuant to his authority as the managing member of, and owner of a controlling interest in, Advisors, also has shared discretionary power to direct the vote and the disposition of the securities of the Issuer held by OPI V and OGH and consequently may also be considered to have indirect beneficial ownership of such securities.